Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma

I Kawaciuk, L Hyrsl, P Dusek, L Jarolim, M Schmidt, V Kaliska, M Chocholaty, S Vesely

. 2008 ; 42 (5) : 406-411.

Jazyk angličtina Země Švédsko

Perzistentní odkaz   https://www.medvik.cz/link/bmc11006340

OBJECTIVE: To evaluate the prognostic significance of symptoms related to renal cell carcinoma (RCC) in comparison with incidentally detected tumours in a group of long-term observed patients. MATERIAL AND METHODS: The study included 396 patients operated for RCC between 1982 and 2001. The patients were classified according to age, gender, detection mode, pathological stage and grade, tumour size, nodal involvement and Eastern Cooperative Oncology Group (ECOG) performance status. Special attention was given to the analysis of duration and quality of symptoms. The endpoint of the study was overall survival, which was assessed with univariate and multivariate analyses using the Kaplan-Meier method, log-rank test and Cox proportional hazards model. RESULTS: Of the 396 patients, 135 (34%) and 261 (66%) presented with incidental and symptomatic RCC, respectively. Compared with incidental cases, symptomatic tumours had significantly larger size (p < 0.0001), and higher pathological stage (p < 0.0001) and grade (p < 0.02). Five-year survival in patients with incidental and symptomatic tumours was 88.1% and 59.4% (p < 0.0001), respectively. In relation to the quality of symptoms, the 5-year survival in patients with local and systemic symptoms was 75.4% and 44.4% (p < 0.0001), respectively. In the group of patients with a history of tumour-related symptoms shorter and longer than 3 months, the 5-year survival was 62.2% and 55.6% (p < 0.0001), respectively. Multivariate analysis found tumour size [hazard ratio (HR) 1.22, p = 0.05] tumour grade (HR 1.44, p = 0.002), tumour stage (HR 1.35, p = 0.001), presence of symptoms (HR 1.36, p = 0.004) and ECOG (HR 1.25, p = 0.005) to be independent prognostic variables. CONCLUSION: Preoperative somatic symptoms and performance status in patients with RCC provide readily available prognostic information in addition to tumour size, stage and grade.

Citace poskytuje Crossref.org

000      
02121naa 2200529 a 4500
001      
bmc11006340
003      
CZ-PrNML
005      
20121203100337.0
008      
110401s2008 sw e eng||
009      
AR
024    __
$a 10.1080/00365590802022151 $2 doi
035    __
$a (PubMed)18932106
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Kawaciuk, Ivan, $d 1944-2020 $7 nlk20000080917
245    10
$a Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma / $c I Kawaciuk, L Hyrsl, P Dusek, L Jarolim, M Schmidt, V Kaliska, M Chocholaty, S Vesely
314    __
$a Department of Urology, 2nd Faculty of Medicine, University Hospital in Motol, Prague, Czech Republic. ivan.kawaciuk@lfmotol.cuni.cz
520    9_
$a OBJECTIVE: To evaluate the prognostic significance of symptoms related to renal cell carcinoma (RCC) in comparison with incidentally detected tumours in a group of long-term observed patients. MATERIAL AND METHODS: The study included 396 patients operated for RCC between 1982 and 2001. The patients were classified according to age, gender, detection mode, pathological stage and grade, tumour size, nodal involvement and Eastern Cooperative Oncology Group (ECOG) performance status. Special attention was given to the analysis of duration and quality of symptoms. The endpoint of the study was overall survival, which was assessed with univariate and multivariate analyses using the Kaplan-Meier method, log-rank test and Cox proportional hazards model. RESULTS: Of the 396 patients, 135 (34%) and 261 (66%) presented with incidental and symptomatic RCC, respectively. Compared with incidental cases, symptomatic tumours had significantly larger size (p < 0.0001), and higher pathological stage (p < 0.0001) and grade (p < 0.02). Five-year survival in patients with incidental and symptomatic tumours was 88.1% and 59.4% (p < 0.0001), respectively. In relation to the quality of symptoms, the 5-year survival in patients with local and systemic symptoms was 75.4% and 44.4% (p < 0.0001), respectively. In the group of patients with a history of tumour-related symptoms shorter and longer than 3 months, the 5-year survival was 62.2% and 55.6% (p < 0.0001), respectively. Multivariate analysis found tumour size [hazard ratio (HR) 1.22, p = 0.05] tumour grade (HR 1.44, p = 0.002), tumour stage (HR 1.35, p = 0.001), presence of symptoms (HR 1.36, p = 0.004) and ECOG (HR 1.25, p = 0.005) to be independent prognostic variables. CONCLUSION: Preoperative somatic symptoms and performance status in patients with RCC provide readily available prognostic information in addition to tumour size, stage and grade.
590    __
$a bohemika - dle Pubmed
650    _2
$a senioři $7 D000368
650    _2
$a karcinom z renálních buněk $x diagnóza $x chirurgie $x mortalita $x patologie $7 D002292
650    _2
$a diagnostické zobrazování $7 D003952
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a náhodný nález $7 D033162
650    _2
$a nádory ledvin $x diagnóza $x chirurgie $x mortalita $x patologie $7 D007680
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a staging nádorů $7 D009367
650    _2
$a nefrektomie $7 D009392
650    _2
$a prognóza $7 D011379
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $7 D015996
700    1_
$a Hyršl, Lubomír, $d 1934- $7 nlk20000080920
700    1_
$a Dušek, Pavel $7 xx0069989
700    1_
$a Jarolím, Ladislav, $d 1949- $7 jn20010310079
700    1_
$a Schmidt, Marek $7 xx0105483
700    1_
$a Šturcová Kaliská, Veronika $7 xx0080464
700    1_
$a Chocholatý, Matúš $7 xx0121519
700    1#
$a Veselý, Štěpán. $7 xx0208977
773    0_
$t Scandinavian Journal of Urology & Nephrology $w MED00010606 $g Roč. 42, č. 5 (2008), s. 406-411 $x 0036-5599
910    __
$a ABA008 $b x $y 2
990    __
$a 20110414103749 $b ABA008
991    __
$a 20121203100408 $b ABA008
999    __
$a ok $b bmc $g 833942 $s 698438
BAS    __
$a 3
BMC    __
$a 2008 $b 42 $c 5 $d 406-411 $i 0036-5599 $m Scandinavian journal of urology and nephrology $n Scand J Urol Nephrol $x MED00010606
LZP    __
$a 2011-1B09/jjme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...